内膜增生
再狭窄
新生内膜增生
PI3K/AKT/mTOR通路
河马信号通路
细胞生物学
支架
西罗莫司
下调和上调
信号转导
动脉
心脏病学
癌症研究
内科学
医学
生物
免疫学
效应器
平滑肌
基因
生物化学
作者
Qi Yang,Dong Lei,Shixing Huang,Yang Yang,Chenyu Jiang,Hui Shi,Wenyi Chen,Qiang Zhao,Zhengwei You,Xiaofeng Ye
出处
期刊:Biomaterials
[Elsevier]
日期:2020-11-01
卷期号:258: 120254-120254
被引量:12
标识
DOI:10.1016/j.biomaterials.2020.120254
摘要
Coronary artery bypass graft (CABG) has been confirmed to effectively improve the prognosis of coronary artery disease, which is a major public health concern worldwide. As the most frequently used conduits in CABG, saphenous vein grafts have the disadvantage of being susceptible to restenosis due to intimal hyperplasia. To meet the urgent clinical demand, adopting external stents (eStents) and illuminating the potential mechanisms underlying their function are important for preventing vein graft failure. Here, using 4-axis printing technology, we fabricated a novel biodegradable and flexible braided eStent, which exerts excellent inhibitory effect on intimal hyperplasia. The stented grafts downregulate Yes-associated protein (YAP), indicating that the eStent regulates vein graft remodeling via the Hippo-YAP signaling pathway. Further, as a drug-delivery vehicle, a rapamycin (RM)-coated eStent was designed to amplify the inhibitory effect of eStent on intimal hyperplasia through the synergistic effects of the Hippo and mammalian target of rapamycin (mTOR) signaling pathways. Overall, this study uncovers the underlying mechanisms of eStent function and identifies a new therapeutic target for the prevention of vein graft restenosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI